Erich P Huang
Overview
Explore the profile of Erich P Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
2002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel K, Dal Pra A, Huang E, Singh S, Verma V, Citrin D, et al.
Int J Radiat Oncol Biol Phys
. 2025 Jan;
PMID: 39855400
Purpose: A single-phase 3 trial has demonstrated that prostate radiation therapy with a focal, intraprostatic "microboost" can improve disease control without an overall increase in toxicity. It is unclear how...
2.
Gelikman D, Azar W, Yilmaz E, Lin Y, Shumaker L, Fang A, et al.
BJU Int
. 2024 Dec;
PMID: 39654290
Objectives: To develop and validate a Prostate Imaging-Reporting and Data System (PI-RADS) version 2.1 (v2.1)-based predictive model for diagnosis of clinically significant prostate cancer (csPCa), integrating clinical and multiparametric magnetic...
3.
Patel K, Menon H, Patel R, Huang E, Verma V, Escorcia F
JAMA Netw Open
. 2024 Nov;
7(11):e2447995.
PMID: 39602117
Importance: Several locoregional therapies (LRTs) for nonmetastatic hepatocellular carcinoma (HCC) are available; however, a global comparison of the relative efficacy of each is needed. Objective: To conduct a systematic review...
4.
Yilmaz E, Harmon S, Law Y, Huang E, Belue M, Lin Y, et al.
Radiol Imaging Cancer
. 2024 Oct;
6(6):e240050.
PMID: 39400232
Purpose To evaluate the performance of an artificial intelligence (AI) model in detecting overall and clinically significant prostate cancer (csPCa)-positive lesions on paired external and in-house biparametric MRI (bpMRI) scans...
5.
Patel K, Mena E, Rowe L, Ning H, Cheng J, Salerno K, et al.
Int J Radiat Oncol Biol Phys
. 2024 Oct;
PMID: 39384104
Purpose: This was a phase 1 trial with the primary objective of identifying the most compressed dose schedule (DS) tolerable using risk volume-adapted, hypofractionated, postoperative radiation therapy (PORT) for biochemically...
6.
Harris L, Shankar L, Hildebrandt C, Rubinstein W, Langlais K, Rodriguez H, et al.
J Natl Cancer Inst
. 2024 Jun;
116(10):1562-1570.
PMID: 38867688
The National Institutes of Health-US Food and Drug Administration Joint Leadership Council Next-Generation Sequencing and Radiomics Working Group was formed by the National Institutes of Health-Food and Drug Administration Joint...
7.
Patel K, Rydzewski N, Schott E, Cooley-Zgela T, Ning H, Cheng J, et al.
Int J Radiat Oncol Biol Phys
. 2024 Mar;
119(5):1471-1480.
PMID: 38428681
Purpose: NCT03253744 is a phase 1 trial with the primary objective to identify the maximum tolerated dose (MTD) of salvage stereotactic body radiation therapy (SBRT) in patients with local prostate...
8.
Patel K, Rydzewski N, Schott E, Cooley-Zgela T, Ning H, Cheng J, et al.
Pract Radiat Oncol
. 2023 Jul;
13(6):540-550.
PMID: 37442430
Purpose: NCT03253744 was a phase 1 trial to identify the maximum tolerated dose (MTD) of image-guided, focal, salvage stereotactic body radiation therapy (SBRT) for patients with locally radiorecurrent prostate cancer....
9.
Raunig D, Pennello G, Delfino J, Buckler A, Hall T, Guimaraes A, et al.
Acad Radiol
. 2022 Dec;
30(2):159-182.
PMID: 36464548
Multiparametric quantitative imaging biomarkers (QIBs) offer distinct advantages over single, univariate descriptors because they provide a more complete measure of complex, multidimensional biological systems. In disease, where structural and functional...
10.
Huang E, OConnor J, McShane L, Giger M, Lambin P, Kinahan P, et al.
Nat Rev Clin Oncol
. 2022 Nov;
20(2):69-82.
PMID: 36443594
Computer-extracted tumour characteristics have been incorporated into medical imaging computer-aided diagnosis (CAD) algorithms for decades. With the advent of radiomics, an extension of CAD involving high-throughput computer-extracted quantitative characterization of...